|
Reference/Study Question
|
Methods
|
|
Breast cancer evaluation and follow-up: A survey of the Ohio Chapter of the American College of Surgeons (Stark and Crowe, 1996)
_________
What are the practice philosophies of Ohio general surgeon fellows regarding evaluation and follow-up?
|
Method: 1994 survey of 764 general surgeons, fellows in the Ohio chapter of the American College of Surgeons.
|
|
Sample: 261 responses to the survey were evaluable (RR = 34%).
|
|
Statistical method: Descriptive statistics.
|
|
Explanatory variables: None.
|
|
Geographic variation in patient surveillance after radical prostatectomy (Powell et al., 2000)
|
Method: 1997 physician survey. Examined three frequently used modalities:
-
Digital rectal exam
-
Urinalysis
-
Serum PSA
|
|
How tumor stage affects American urologists’ surveillance strategies after prostate cancer surgery (Johnson et al., 2000)
|
And eight infrequently used modalities:
-
Chest X ray
-
Computed tomography of abdomen and pelvis
-
Magnetic resonance imaging (MRI)
-
Radionuclide bone scan
-
Multichannel blood chemistry
-
Complete blood count (CBC)
-
Serum prostatic acid phosphatase
-
Monoclonal antibody scan
Attitudes toward follow-up were also assessed.
|
|
Current follow-up strategies after radical prostatectomy: A survey of American Urological Association urologists (Oh et al., 1999)
|
|
The age of the urologist affects the postoperative care of prostate carcinoma patients (Tsai et al., 1999)
_________
How does tumor stage and urologist geographic location and age influence variability of surveillance after radical prostatectomy (Stage TNM I-II, III)?
|
Sample: 4,467 members of the American Urological Association (randomly selected from total of 12,500 members) mailed survey in 1997. RR = 32% (1,416/4,467); 1,050/1,416 responses were usable; 28% of usable responses (290/1,050) were from urologists practicing outside of United States.
|
|
Statistical methods: Repeated measures analysis of variance.
|
|
Explanatory variables: Location in 24 MSAs, U.S. census region, HMO penetration.
|
